We recently announced the winners of the 2017 CiteAb Antibody Awards, and today we feature the winner profile here on our blog for the category of ‘Custom antibody or alternative affinity reagent supplier 2017’. The winners of this category for 2017 are Bio-Rad, headquartered in California, USA, and trading internationally. This category recognises a supplier […]
We recently announced the winners of the 2017 CiteAb Antibody Awards, and today we feature the winner profile here on our blog for the prestigious category of ‘Most Exciting Antibody Validation Initiative 2017’. The winners of this category for 2017 are Abcam, headquartered in the UK and trading internationally. This category was extremely competitive and […]
We recently announced the winners of the 2017 CiteAb Antibody Awards, and today we feature our first winner profile here on our blog for the prestigious category of ‘Researchers’ Choice’. The winners of this category for 2017 are Cell Signaling Technology, headquartered in the USA and trading internationally. The Researchers’ Choice award is of specific […]
For the first time in 42 years, use of monoclonal antibodies has overtaken polyclonals in the research antibody market. Production of monoclonal antibodies was first described by Georges Köhler and César Milstein in 1975, and the pair were awarded the Nobel Prize in 1984. Monoclonal antibodies then became the dominant antibodies used in therapeutic and […]
This year, as part of the CiteAb Antibody Awards, we offered researchers the chance to be entered into a prize draw for nominating their favourite antibody suppliers. This category had a large number of entries this year, and we selected the prize-winning nominator at random. Congratulations to Netanya Spencer of the Joslin Diabetes Center at Harvard […]
Thank you all for making this years awards more exciting than ever before – we’ve had a huge number of entries which our judges are now going through. We’re also scrutinising CiteAb data to establish winners for the data-driven categories. Award winners will be announced here on our blog on Monday 30th January at midday, […]
Our latest data set outlines the protein targets most used for Chromatin Immunoprecipitation (ChIP) – it was created by our team looking specifically at antibody citations over the past ten years that carried out ChIP and working out what the most commonly used protein targets for the antibodies were. Dr Andrew Chalmers, founder of CiteAb, […]
Not all research antibodies can be bought off the shelf, but for researchers it isn’t always easy to know which company to trust to produce reliable custom products. This award celebrates the most reliable suppliers of custom antibodies or alternative affinity reagents – those that offer excellent service and fill a niche in the market. […]
Every sector has its champions – those individuals who, over the course of their careers, make an outstanding contribution and shape the future of the industry. Here at CiteAb we’re keen to recognise and promote individuals who have made a significant contribution to the research antibody industry over a sustained period of time with a […]
Our team here at CiteAb would like to wish all of our visitors a very happy New Year – we hope you have a great 2017. For us here at CiteAb there have been many new milestones in 2016 and plenty of reasons to celebrate. For example, there are now twice as many researchers using […]
CiteAb is the largest citation-ranked antibody search engine and database. It provides an impartial way to find and compare antibodies that work.
We use our database of antibody publications to produce unique antibody market data, income from this data allows us to remain free to list and impartial.
Publication metadata is provided by PubMed®, a database of the US National Library of Medicine.
PubMed® is a registered trademark of US National Library of Medicine.
Company registered in England #08530854. VAT #179706954.
In partnership with
© CiteAb 2012-2015. All Rights Reserved.